On the morning of June 22, 2021, the Nutrition Promotion Special Fund of China Health Entry Foundation and Guangdong Shuangjun Biotechnology Co., Ltd. jointly held the "Closed-door Seminar of Experts on Health Evidence of Vitamin K2 and Nattokinase" at the Conference Center of Xijiao Hotel in Shanghai to discuss the latest achievements and research directions in the field of vitamin K2 and nattokinase research and development, and promote the development of China's health industry.
Experts present at the meeting were: Chairman of the Nutrition Promotion Special Fund of the China Health Promotion Foundation / Yang Yuexin, Chairman of the Nutrition Society of China, Yang Xiaoguang, Researcher of the Institute of Nutrition and Health of the Chinese Center for Disease Control and Prevention, Yan Weixing, Former Deputy Secretary of the Party Committee of the National Center for Food Safety Risk Assessment, Li Changling, Former Vice Dean of the School of Pharmacy of Peking University, Xiao Hanfa, Chairman of the Supervisory Board of the China Association for Quality Management of Medicine, Professor Wang Zhu, Researcher of the Institute of Nutrition and Health of the Chinese Center for Disease Control and Prevention, Professor Li Ying, Vice Dean of School of Public Health, Harbin Medical University, Professor Yu Kang, Chief Physician of department of Clinical Nutrition, Peking Union Medical College Hospital, Professor Bi Qi, Chief Physician of Department of Neurology, Beijing Anzhen Hospital Affiliated to Capital Medical University, Director Tan Jing, Department of Hematology, Affiliated Hospital of Southwest Jiaotong University/Chengdu Third People's Hospital, Professor Li Shuzhuang, School of Basic Medical Sciences, Dalian Medical University, Professor Xu Feng, Director of Shuangjun Biotin K2 Research Center, Shenyang Pharmaceutical University, Professor Zhang Meixia, School of Basic Medical Sciences, China Medical University, Professor Lin Yiguang of the University of Technology Sydney, Australia, Wu Fei, Deputy Director of the Public Welfare Department of the China Health Promotion Foundation, Wang Xin, Secretary-General of the Nutrition Promotion Special Fund of the China Health Promotion Foundation, Dr. Zhou Jianlie, Chief Editor of the Website of Vitamin K2 Today, and Dr. Chen Jiepeng, Chief Scientist of Shuangjun Biology.
Vitamin K2 and nattokinase health evidence experts discuss the scene behind closed doors
Dean Li Changling, former Vice Dean of the School of Pharmacy of Peking University, served as the guest host
At the meeting, Dr. Chen Jiepeng, Chief Scientist and Managing Director of Shuangjun Biology, delivered a speech on "New Discoveries : Making Life More Exciting". As a demonstration base for the production quality management of natto physiological active substances in China, Shuangjun Bio has successfully promoted the formulation of national standards for vitamin K2 (fermentation method) and local standards for nattokinase, taken the lead in carrying out real-world clinical research on health food in China, established a vitamin K2 research center, an antithrombolytic innovative drug research center, and set up a "vitamin K2 scientific research fund" to promote the high-quality development of the industry with innovative scientific research and clinical research.
Dr. Jiepeng Chen, Chief Scientist and Managing Director of Shuangjun Biologics, delivered a speech
Then, Wang Xin, Secretary General of the Nutrition Promotion Special Fund of the China Health Promotion Foundation, interpreted the "Vitamin K2 Public Welfare Project". According to reports, the China Health Promotion Foundation Nutrition Promotion Special Fund cooperated to set up the "Vitamin K2 and Health Evidence Research Project" to continue to support more vitamin K2 and health-related evidence research, and further improve the research level of vitamin K2 and its application in the field of health management.
Wang Xin, Secretary-General of the Nutrition Promotion Special Fund of the China Health Promotion Foundation
Subsequently, the experts and scholars conducted in-depth analysis of the development of vitamin K2 and nattokinase industry from the aspects of health efficacy research, industry standard formulation, process technology improvement, product application innovation, etc., fully affirmed the scientific research achievements of outstanding front-line scientists in the industry and scientific research enterprises such as Shuangjun Biology, and also put forward many valuable suggestions for the future development direction of health research.
Yang Yuexin, chairman of the Nutrition Promotion Special Fund of the China Health Promotion Foundation and chairman of the Chinese Nutrition Society, delivered a speech
Wu Fei, deputy director of the Public Welfare Department of the China Health Promotion Foundation, delivered a speech
Expert discussion
At present, the research and popularization of vitamin K2 and nattokinase in China is still in the initial stage of development, and more scientists and science popularization workers are still needing to work together. As the original research enterprise of natural vitamin K2 (MK-7), Shuangjun Bio has set up a vitamin K2 research fund under the organization of the Chinese Nutrition Society and the China Health Promotion Foundation to further expand the basic research related to vitamin K2, the relationship between vitamin K2 and nutrition, health and disease prevention and control, and the application technology research of vitamin K2 in the form of project bidding, which will greatly promote the breakthrough development of international vitamin K2 research.